Trademarkia Logo

Australia

AU$
LYPTIMZIA
Cancelled: Cancelled at the request of IB

Last updated on 8 Nov 2023

Owner Info

Novartis AG

CH-4002 Basel

SWITZERLAND,

Serial Number

2055456 filed on 7 Nov 2019

Correspondent

Novartis AG

CH-4002 Basel,

SWITZERLAND,

LYPTIMZIA

Classification Information


Class [005]
Cardiovascular pharmaceuticals; pharmaceutical preparations for the treatment of hypercholesterolemia.

Mark Details


Serial Number

2055456

Registered On

7 Nov 2019

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

13 May 2019

Mark Type

US

Legal History


Show more

Status DateAction Taken
8th Nov 2023Status change to Voided
21st Aug 2021Full Assignment - Subsequent Owner Registered Published
19th Aug 2021Full Assignment Requested
26th May 2020International Registration in Australia Protected correspondence sent
25th May 2020IP Right Registration Published
25th May 2020Status change to Registered/Protected
18th Mar 2020Application Accepted correspondence sent
17th Mar 2020IP Right has been Examined
17th Mar 2020IP Right Acceptance Published
17th Mar 2020Status change to Accepted